Serica Technologies Company Profile - aVenture Research
Tissue Regeneration was founded to commercialize doctoral research in biomedical engineering, first pursuing a tissue-engineered ligament grown from adult stem cells before shifting to silk-based biomaterials, and was later renamed Serica Technologies. It is a medical device company developing silk-based biomaterial platforms for tissue rejuvenation within orthopedics and sports medicine as well as aesthetic and reconstructive plastic surgery. Its lead products were SeriACL, used for anterior cruciate ligament repair, and SeriCuff for rotator cuff injury.
The company aimed to create an off-the-shelf tissue scaffold supporting ligament regeneration after surgical repair, avoiding autograft methods that take healthy tissue from another part of the body. Its silk-based products resorb more slowly than common structural proteins like collagen, and their breakdown rate can be predicted and controlled. Its products are developed for use by clinicians and patients.